| 纳米银在小鼠体内的组织分布 |
| |
| 引用本文： | 张姗姗,薛玉英,唐萌,张婷,刘晓闰,张鹏,张智勇. 纳米银在小鼠体内的组织分布[J]. 东南大学学报(自然科学版), 2012, 42(2): 388-392. DOI: 10.3969/j.issn.1001-0505.2012.02.037 |
| |
| 作者姓名： | 张姗姗 薛玉英 唐萌 张婷 刘晓闰 张鹏 张智勇 |
| |
| 作者单位： | 1.东南大学环境医学工程教育部重点实验室,南京210009;东南大学江苏省生物材料与器件重点实验室,南京210009;东南大学公共卫生学院,南京210009;2.中国科学院高能物理研究所,北京,100049 |
| |
| 基金项目： | 国家重点基础研究发展计划(973计划)资助项目(2011CB933404);国家自然科学基金资助项目(30972504);江苏省自然科学基金资助项目(BK2011606);东南大学科技基金资助项目(KJ2010440) |
| |
| 摘 要： | 将分散在生理盐水中的纳米银以尾静脉注射的方式注入小鼠体内,采用电感耦合等离子质谱(ICP-MS)法检测其在小鼠体内的组织分布情况,并利用DAS药物动力学软件分析其在血液中的动力学参数.实验结果显示:纳米银经尾静脉注射进入小鼠体内后,血液中的w(Ag)在染毒1h内呈快速下降趋势,其后的24 h内w(Ag)处于平稳状态;纳米银在体内的消除半衰期为22.8 h,分布容积为26.8 L/kg;进入体内的纳米银可随血液循环快速分布到全身各脏器,6h后即可在小鼠的多个主要脏器中检测到银的存在,其中脾脏中的w(Ag)约为203 μg/g;滞留在体内的银主要分布在肝脏和脾脏中.由此可见,纳米银具有较高的组织亲和力,肝脏和脾脏可能是纳米银的主要蓄积作用靶器官.
|
| 关 键 词： | 纳米银 尾静脉注射 组织分布 |
Biodistribution of nanosilvers in mice |
| |
| Zhang Shanshan , Xue Yuying , Tang Meng , Zhang Ting , Liu Xiaorun , Zhang Peng , Zhang Zhiyong. Biodistribution of nanosilvers in mice[J]. Journal of Southeast University(Natural Science Edition), 2012, 42(2): 388-392. DOI: 10.3969/j.issn.1001-0505.2012.02.037 |
| |
| Authors: | Zhang Shanshan Xue Yuying Tang Meng Zhang Ting Liu Xiaorun Zhang Peng Zhang Zhiyong |
| |
| Affiliation: | 1 Key Laboratory of Environmental Medicine and Engineering of Ministry of Education,Southeast University,Nanjing 210009,China)(2Jiangsu Key Laboratory for Biomaterials and Devices,Southeast University,Nanjing 210009,China)(3School of Public Health,Southeast University,Nanjing 210009,China)(4 Institute of High Energy Physics,Chinese Academy of Sciences,Beijing 100049,China) |
| |
| Abstract: | Nanosilvers dissolved in saline were injected intravenously by tail vein into mice.The concentration of nanosilvers in blood and organs was detected by the inductively coupled plasma mass spectrometry(ICP-MS),and the kinetic parameters in blood were evaluated by the drug and statistical software(DAS).The experimental results indicate that the concentration of nanosilvers in blood is dropped rapidly in one hour after injection,and gradually becomes stable in the following 24 h.The elimination half-life in blood is 22.8 h,and the volume of distribution is 26.8 L/kg.After injection,the nanosilvers are quickly distributed to the organs following blood circulation.After 6 h the nanosilver can be detected in the main organs,and the maximum concentration of nanosilvers,about 203 μg/g,is in spleen.The majority of the nanosilvers are accumulated in liver and spleen.Therefore,nanosilvers have good biocompatibility with the tissues.The liver and spleen are the main target organs for nanosilvers. |
| |
| Keywords: | nanosilver tail vein injection biodistribution |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
